Image 1
Hydrochlorothiazide Capsule, Gelatin Coated
Product Images NDC 0591-0347
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 0591-0347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a description of a medication named Hydrochlorothiazide which comes in the form of capsules with 125 mg of Fydrohiorohiazde USP. It was manufactured by Watson Pharm Private Limited in India and must be kept stored at a temperature between 20°-25°C. The medication is only available through prescription. The packaging contains instructions and additional information that should be provided by a healthcare professional. It is important to keep the medication out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
